Evidence map›Paper›PMID 33789339›Full record

ArticleNature2021

A myeloid-stromal niche and gp130 rescue in NOD2-driven Crohn's disease.

Shikha Nayar, Joshua K Morrison, Mamta Giri, Kyle Gettler, Ling-Shiang Chuang, Laura A Walker, Huaibin M Ko, Ephraim Kenigsberg, Subra Kugathasan, Miriam Merad and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
16.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 125 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. The role of theFrontiers in microbiology · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Shikha NayarDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0001-8519-4569
Joshua K MorrisonDepartment of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0003-4174-6338
Mamta GiriThe Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Kyle GettlerDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ling-Shiang ChuangDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0001-5054-1305
Laura A WalkerThe Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Huaibin M KoDepartment of Pathology, The Mount Sinai Hospital, New York, NY, USA.ORCID http://orcid.org/0000-0003-1062-2383
Ephraim KenigsbergDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-4107-3295
Subra KugathasanDepartment of Pediatric Gastroenterology, Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-8686-4189
Miriam MeradThe Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-4481-7827
Jaime ChuDepartment of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Judy H ChoThe Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. judy.cho@mssm.edu.ORCID http://orcid.org/0000-0002-7959-0466
Icahn School of Medicine at Mount Sinai · USChild Health and Development Institute · USColumbia University Irving Medical Center · USEmory University · US

Funding

Yale University Inflammatory Bowel Disease Genetics Research CenterU01DK062422 · NIDDK · YALE UNIVERSITY · PI Ling-shiang Chuang · 2002 to 2026
$10.8M
Integrative Genomic Analyses of Macrophages in Crohns DiseaseR01DK106593 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHO, JUDY H. · 2016 to 2020
$3.8M
Intestinal single cell analyses and population differences in innate immunity in Crohn's disease drive treatment response and clinical heterogeneity: towards Precision IBDR01DK123758 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHO, JUDY H. · 2020 to 2023
$2.9M
Mannose metabolism as a regulator of hepatic stellate cell activation and fibrosisR01DK121154 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHU, JAIME C · 2020 to 2024
$2.3M
NIDDK NIH HHS R01 DK106593NIDDK NIH HHS R01 DK121154NIDDK NIH HHS R01 DK123758NIDDK NIH HHS U01 DK062422
6 · The paper itself

Abstract

Crohn's disease is a chronic inflammatory intestinal disease that is frequently accompanied by aberrant healing and stricturing complications. Crosstalk between activated myeloid and stromal cells is critical in the pathogenicity of Crohn's disease

Indexed as

AllelesAnimalsCollagenCrohn DiseaseCytokine Receptor gp130Disease Models, AnimalFemaleFibroblastsHumansIleitisIndolesInterleukin-11Lipopolysaccharide ReceptorsMacrophagesMaleMyeloid CellsbazedoxifeneCollagenCytokine Receptor gp130IndolesInterleukin-11Lipopolysaccharide ReceptorsNOD2 protein, humanNOD2 protein, zebrafishNod2 Signaling Adaptor ProteinReceptor, Platelet-Derived Growth Factor alphaSTAT3 protein, humanSTAT3 Transcription FactorWT1 ProteinsZebrafish Proteins

Identifiers

PMID33789339
PMCPMC8284870
OpenAlexW3142230270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.